Brainsway Ltd. (BWAY) – StreetInsider.com Reports
-
Brainsway (BWAY) PT Raised to $13 at H.C. Wainwright
-
Brainsway (BWAY) PT Raised to $10 at Oppenheimer
-
BrainsWay Ltd. (BWAY) Tops Q4 EPS by 1c ; Offers Guidance
-
Brainsway (BWAY) PT Raised to $6 at Oppenheimer
-
Raymond James Downgrades Brainsway (BWAY) to Market Perform
-
BrainsWay Ltd. (BWAY) Tops Q3 EPS by 3c
-
Brainsway (BWAY) Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation for Depression
-
Brainsway (BWAY) Enters Partnership with Treatment Provider in Northeast U.S.
-
Brainsway (BWAY) PT Raised to $5.50 at Northland Capital Markets
-
BrainsWay Ltd. (BWAY) Tops Q2 EPS by 3c
-
Brainsway Ltd. (BWAY) Announces Publication of Three New Deep TMS Research Publications
-
Brainsway (BWAY) Announces International Expansion in India
-
Brainsway Ltd. (BWAY) Announces Significant Expansion in Western and Central U.S.
-
Brainsway Ltd. (BWAY) Appoints Ido Marom as CFO
-
Brainsway (BWAY) PT Lowered to $3 at Raymond James
-
BrainsWay Ltd. (BWAY) Tops Q1 EPS by 3c
-
Brainsway (BWAY) PT Lowered to $12 at H.C. Wainwright
-
Brainsway (BWAY) PT Lowered to $5 at Oppenheimer
-
BrainsWay Ltd. (BWAY) Tops Q4 EPS by 1c
-
Brainsway (BWAY) Announces Appointment of Ami Boehm as New Chairman
-
Brainsway (BWAY) Reports Open Market Stock Purchase by Board Member Yossi Ben Shalom
-
Brainsway (BWAY) PT Lowered to $13 at H.C. Wainwright
-
Brainsway (BWAY) PT Lowered to $5 at Northland Capital Markets
-
BrainsWay Ltd. (BWAY) Misses Q3 EPS by 9c
-
Brainsway (BWAY) Announces Significant Private Insurance Coverage from Cigna Corporation for the Treatment of OCD Utilizing Deep TMS
-
BrainsWay Ltd. (BWAY) Reports In-Line Q2 EPS
-
Brainsway (BWAY) PT Lowered to $10 at Raymond James
-
Brainsway Ltd. (BWAY) Reports Q1 Revenue of $8M, Net Loss of $1.5M
-
Brainsway Ltd. (BWAY) Reports Q4 Results
-
UPDATE: Loop Capital Starts Brainsway (BWAY) at Buy
-
Brainsway (BWAY) PT Raised to $15 at H.C. Wainwright
-
BrainsWay Ltd (BWAY:TA) (BWAY) PT Raised to $17 at Ladenburg Thalmann, Following Earnings
-
Brainsway (BWAY) Announces FDA Clears BrainsWay Deep TMS System for Decreasing Anxiety Symptoms in Depressed Patients
-
BrainsWay Ltd (BWAY:TA) (BWAY) PT Raised to $16.50 at Ladenburg Thalmann, Following Earnings
-
UPDATE: H.C. Wainwright Starts Brainsway (BWAY) at Buy
-
Brainsway (BWAY) PT Raised to $15 at Cantor Fitzgerald on OCD Reimbursement Success
-
Brainsway Ltd. (BWAY) Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS
-
Brainsway Ltd. (BWAY) granted Health Canada approval for the Brainsway Deep TMS System
-
Pre-Open Stock Movers 04/26: (PFPT) (SJ) (GSX) Higher; (BNTX) (ACI) (MRNA) Lower (more...)
-
Brainsway (BWAY) Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder
-
UPDATE: Northland Capital Markets Starts Brainsway (BWAY) at Outperform
-
Brainsway Ltd. (BWAY) Granted FDA 510(k) approval for its Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System
-
Brainsway (BWAY) PT Raised to $15 at Oppenheimer
-
Brainsway Ltd. (BWAY) Announces Proposed Public Offering of ADSs
-
Brainsway Ltd. (BWAY) Halted, News Pending
-
Brainsway (BWAY) PT Raised to $12 at Raymond James
-
Brainsway (BWAY) PT Raised to $14.75 at Ladenburg Thalmann
-
Brainsway (BWAY) PT Raised to $13 at Cantor Fitzgerald
-
UPDATE: Brainsway Ltd. (BWAY) Reports Deep TMS System Granted 510(k) FDA Clearance for Smoking Addiction in Adults
-
Brainsway (BWAY) PT Lowered to $9 at Raymond James
Back to BWAY Stock Lookup